About 100 reports

This study covers the latent demand outlook for over-the-counter (OTC) generic drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all...

  • Generic Drug
  • China
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for cold-chain generic drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is...

  • Generic Drug
  • Cold Chain
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for over-the-counter (OTC) generic drugs across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city...

  • Generic Drug
  • India
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for over-the-counter (OTC) generic drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share...

  • Generic Drug
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for generic prescription drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is...

  • Generic Drug
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for generic prescription drugs across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of...

  • Generic Drug
  • India
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for generic prescription drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter...

  • Generic Drug
  • China
  • Disposable Income
  • Purchasing Power Parity

Abstract Generic Pharmaceutical Manufacturing in Massachusetts Generic pharmaceutical and medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection, and...

  • Generic Drug
  • Private Health Insurance
  • Pharmaceutical Production
  • Employment Income

The rapid growth of the generic industry has come with a number of challenges, such as heavy competition, including from authorized generics and government-mandated price cuts. All contribute to diminishing prices and ever decreasing margins. In this era of increased pharmaceutical industry competition, success for generic drug companies is...

  • Pharmaceutical
  • Generic Drug

U.S. Specialty Injectable Generics Market Analysis By Therapeutic Use (Oncology, Cardiovascular, Central Nervous System, Infectious Diseases, Autoimmune Disorders), And Segment Forecasts, 2014 - 2025 The U.S. specialty injectable generics market is expected to reach USD 27.8 billion by 2025 High demand for...

  • Infectious Disease
  • Generic Drug
  • Autoimmune Disease
  • United States
  • Number Of Enterprises
  • Generic Drugs Market Share

Specialty Generics Market Analysis By Type (Injectables, Oral), By Application (Oncology, Inflammatory Conditions, Multiple Sclerosis, Hepatitis C), By End-use, And Segment Forecasts, 2014 - 2025 The global specialty generics market is expected to reach USD 174.9 billion by 2025, according to a new report by Grand View Research,...

  • Generic Drug
  • Neurological Disorder
  • Chronic Disease
  • World
  • United States
  • APAC
  • Chronic Disease Prevalence
  • Disposable Income

The Global Active Pharmaceutical Ingredients (API) Market is poised to grow at a CAGR of around 6.6% over the next decade to reach approximately $238.8 billion by 2025. Some of the prominent trends that the market is witnessing include, Growing Geriatric Population, Rapid growth in biopharmaceuticals sector and Technological...

  • Pharmaceutical
  • Prescription Drug
  • Biopharmaceutical
  • Musculoskeletal Disorder
  • Generic Drug
  • Endocrine Disease
  • Cardiovascular Disease
  • Neurological Disorder
  • World

Global Industrial Microbiology Market to Witness Exponential Growth from 2017 to 2025 The industrial microbiology market is a rapidly growing market as pharmaceuticals and biotechnology as well as food and beverages industry and its other end users are emerging due to increasing customer preference towards use of nutraceuticals,...

  • Pharmaceutical
  • Biotechnology
  • Generic Drug
  • OTC
  • World
  • Generics Use

About Modular Cleanroom A cleanroom is an environmentally controlled enclosure determined by the number of airborne particulates, temperature, air pressure, humidity, airflow patterns and motion, static charges, and lighting. Adhesion of particles is prevented to ensure high-quality, reliable products and operations. The cleanliness...

  • Semiconductor
  • Generic Drug
  • Healthcare
  • Automotive
  • Aerospace And Defense
  • APAC
  • Prescription Drug Sales
  • Drug Approval

Dr. Reddy’s Laboratories Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Dr. Reddy’s Laboratories Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers...

  • Pharmaceutical
  • Generic Drug
  • Chemical
  • United Kingdom
  • United States
  • India
  • Pharmaceutical Exports
  • Pharmaceutical Production

KEY FINDINGS The North America opioid induced constipation drug market is expected to be the fastest growing market during the forecast period of 2017-2025 with an expected CAGR growth of 5.72%. The revenue generated by the market is expected to increase from $840.4 million in 2016 and reach $1382.73 million by 2025. MARKET...

  • OTC
  • Healthcare
  • Generic Drug
  • Digestive System Disorder
  • Gastrointestinal Drug
  • North America
  • Health Expenditure

This latest market research report titled Generic Drugs Market in India 2017 covers the current and future state of the generics market in the country. Demand for generics is expected to increase as patients shift from the more expensive branded drugs to the lower priced generics. Various initiatives from the government to increase the usage...

  • Generic Drug
  • India
  • Generics Use

The generic injectable drug segment is a rapidly evolving and highly competitive market that lacks a true data compass to assist decision makers in mapping strategies for success in this segment. Attempting to determine the optimal time to file an ANDA application is a process that can be worth significant profits for first-to-filers. But...

  • Generic Drug
  • World

The global active pharmaceutical pngredients (API) market is expected to reach a value of USD 239.8 billion by 2025, based on a new report by Grand View Research, Inc. The rising prevalence of lifestyle-induced & age-related diseases and cancer is projected to drive the market over the forecast period. Advancements in recombinant molecular...

  • Generic Drug
  • APAC
  • World
  • Cause-Specific Mortality Rate

The generic oral liquid dosage form drug segment is a rapidly evolving and highly unpredictable environment that has been a challenge to decision makers attempting to map strategies for success in this segment. There are 309 distinct APIs for which there is at least one approved generic oral liquid dosage form ANDA. These 309 APIs...

  • Generic Drug

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global generics industry. Over the years, the global generic drugs industry has grown strongly owing partly to the fact that the period for patent...

  • Pharmaceutical
  • Generic Drug
  • Drug Development
  • APAC
  • World
  • China
  • Japan
  • India
  • Generics Use
  • Generic Drugs Market Share

A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use. Generic drugs are less expensive because generic manufacturers don't have the investment costs of the developer of a new drug. New drugs are developed under patent protection. The...

  • Pharmaceutical
  • Generic Drug
  • United States
  • Drug Approval
  • Health Expenditure

“US Cancer Generics Market Outlook 2022” report gives comprehensive insight on the various indicators and trend analysis related to the emergence and integration of cancer generics drugs in mainstream pharmaceutical market in US. The report analyzes various clinical and non-clinical parameters responsible for the growth on cancer generics...

  • Oncology
  • Generic Drug
  • United States
  • Generic Drugs Market Share

Lupin Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Lupin Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings,...

  • Generic Drug
  • Private Placement
  • United States
  • Pharmaceutical Exports
  • Prescription Drug Sales

Tracking a Moving Target The generic solid dosage form drug segment is a rapidly evolving and highly unpredictable environment that has been a challenge to decision makers attempting to map strategies for success in this segment. There are 597 distinct APIs for which there is at least one approved generic solid dosage form ANDA....

  • Healthcare
  • Managed Care
  • Pharmaceutical
  • Generic Drug
  • Clinical Trial
  • Chronic Disease

The genitourinary drugs market is expected to reach USD 29.7 billion by 2024, according to a new study by Grand View Research, Inc. This sector is expected to be driven by high R&D investments undertaken by the key companies, which is expected to result in the large-scale development of new drug candidates. This is presumed to increase the...

  • Drug Development
  • Healthcare
  • Proteomics
  • Cancer Immunotherapy
  • Clinical Research
  • Targeted Therapy
  • Generic Drug
  • Genitourinary System Disease
  • World
  • Health Expenditure

The Future of Generic Drugs and Strategies for Commercial Success Summary Generic drugs are identical or bioequivalent to branded drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded...

  • Generic Drug
  • World
  • Generics Use
  • Drug Approval

Within the pharmaceutical industry, the oncology market is growing at a rapid pace owing to the rising incidences of cancer. In 2015, 15.2 Million new cancer cases were registered across the globe. This number is forecasted to increase to a value of 19.3 Million by 2025. Furthermore, the patent expiry of blockbuster cancer drugs is another...

  • Generic Drug
  • Cancer
  • World
  • Cancer Incidence

Summary Par Pharmaceutical Holdings Inc (Par Pharmaceutical Holdings) carries out the research, development, manufacture, commercialization and distribution of generic and branded drugs in the US. Its generic products include oral solids, oral suspensions, gels, nasal sprays, and injectables. It also markets authorized in-licensed...

  • Pharmaceutical
  • Cough And Cold
  • Nasal Drug Delivery
  • Catalog Shopping
  • Healthcare
  • Supermarket
  • Generic Drug
  • Hospital
  • Shopping Center
  • Pharmacy
  • APAC
  • North America
  • Europe
  • Middle East
  • India
  • Africa

Access to therapeutic drugs form an integral part of any successful healthcare system. The high cost of drugs, however remains a barrier to accessibility and improved health to the majority of the South African population. The promotion of generic drug consumption was the answer to this issue, with its massive cost-saving mechanism in regard...

  • Generic Drug
  • Healthcare
  • South Africa